New earthquake of magnitude 8 in the world of tennis. Iga Swiatek was suspended for a month for doping after testing positive for a banned substance, in this case trimetazidine, in a sample taken out of competition. The player has already almost served her sentence between September 12 and October 4, that is to say at the start of the procedure.
“The International Tennis Integrity Agency (Itia) confirms that Polish tennis player Iga Swiatek has accepted a one-month suspension (…), after testing positive for a banned substance, trimetazidine, in a sample taken out of competition in August 2024”, writes the body in a press release, which accepted the thesis of “contamination of a medicine” and considered that “the degree of fault of the player” was “the lowest of the spectrum” .
Traces of trimetazidine were found in melatonin produced and sold in Poland, which she took for sleep problems and jet lag, explains the ITIA. As it considers “the violation” of anti-doping regulations “unintentional”, the anti-doping body proposed a one-month suspension to the former world No.1 on November 27, a sanction accepted by the player.
Only eight days of suspension left
During these three weeks, she was unable to participate in three tournaments on the Asian tour, including two WTA 1000s, in Beijing and Wuhan. He only has eight days of suspension left to serve, until December 4, specifies the ITIA.
This announcement echoes the affair in which Jannik Sinner is embroiled: after a double positive test in March, initially cleared by the ITIA, the world No.1 is now under threat of suspension since the The World Anti-Doping Agency (WADA) appealed the decision not to sanction him. It’s starting to do a lot for the world of the yellow ball.
